Skip to content
Screener

PROCEPT BioRobotics Corporation PRCT Total Liabilities & Equity

Total Liabilities & Equity at other companies

TFX
TeleflexTFX
$6.79B-8.0%
Boston Scientific logo
Boston ScientificBSX
$44.35B+10.5%
Intuitive Surgical logo
Intuitive SurgicalISRG
$20.88B+3.5%
Apyx Medical Corporation logo
Apyx Medical CorporationAPYX
$63.03M+4.8%
PDE
Pro-Dex, Inc.PDEX
$74.98M+16.7%
Microbot Medical logo
Microbot MedicalMBOT
$73.37M+121%

Other financials

Income statement

See full
Revenue$94.5M+19.3%
Gross profit$62.4M+20.5%
Operating income-$27.4M-23.4%
Net income-$26.9M-37.2%
EPS (diluted)-$0.47-34.3%

Balance sheet

See full
Cash & equivalents$11.4M-96.3%
Total debt$77.5M-2.4%
Total equity$340.1M-11.9%
Total assets$479.4M-6.6%

Cash flow

See full
Operating cash flow-$19.3M-28.0%
CapEx$3.0M+5.4%
Free cash flow-$22.2M-24.4%

Valuation

See full
Market cap$1.17B-25.9%
Enterprise value$1.24B
P/S3.5×

Profitability

See full
Gross margin64.2%0.0pp
Operating margin-33.9%+0.5pp
Net margin-32.5%+2.2pp
FCF margin-25.2%-4.6pp

Returns & leverage

See full
Return on equity-30.2%+5.2pp
Debt / equity0.2×0.0×
Current ratio6.5×-2.7×

Where this comes from

Reported directly by PROCEPT BioRobotics Corporation in its filing.

Tagged under the XBRL concept us-gaap:LiabilitiesAndStockholdersEquity.

The source filing: PROCEPT BioRobotics Corporation’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 4:14 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001588978-26-000030
Line itemJune 30, 2026December 31, 2025
Common stock, $0.00001 par value;
Authorized shares: 300,000 at June 30, 2026 and December 31, 2025
Issued and outstanding shares: 57,247 and 56,323 at June 30, 2026 and December 31, 2025, respectively
Additional paid-in capital1,040,1041,007,390
Accumulated other comprehensive gain (loss)2237
Accumulated deficit(700,056)(641,557)
Total stockholders’ equity340,070365,870
Total liabilities and stockholders’ equity$479,352$508,081

Item 1. Condensed Consolidated Financial Statements (unaudited)

FAQ

What is PROCEPT BioRobotics Corporation's total liabilities & equity?
PROCEPT BioRobotics Corporation (PRCT) reported total liabilities & equity of $479.35M in Q2 2026.
How has PROCEPT BioRobotics Corporation's total liabilities & equity changed year-over-year?
PROCEPT BioRobotics Corporation's total liabilities & equity decreased by 6.6% year-over-year, from $513.05M to $479.35M.
What is the long-term trend for PROCEPT BioRobotics Corporation's total liabilities & equity?
Over 5 years (2020 to 2025), PROCEPT BioRobotics Corporation's total liabilities & equity has grown at a 32.2% compound annual growth rate (CAGR), from $125.97M to $508.08M.
What does total liabilities & equity mean?
Total assets = total liabilities + total equity. This must always balance — a fundamental accounting identity.

Ask your AI about PROCEPT BioRobotics Corporation's total liabilities & equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude